Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge
2005 ◽
Vol 55
(7)
◽
pp. 761-774
◽
Keyword(s):
Keyword(s):
2016 ◽
Keyword(s):